Originally recorded on Thursday, July 29th at 2PM ET
Request a link to the recording of this webinar where the speakers take a high-level look into what pharmaceutical regulatory teams in Canada need to know about the complexities of preparing Product Monograph labeling in XML and why they should get started now.
Health Canada entered Phase II of the Voluntary Submission phase June 14, 2021 prompting many questions from regulatory teams. Gary Saner and David Wilson of Reed Tech took a deeper dive into the following topics:
Request a link to this webinar recorded on Thursday, July 29th to learn more and have your questions answered by the subject-matter experts at Reed Tech.
Reed Tech is the provider of best-in-class information-based solutions and services to meet the needs of the life sciences industry, government agencies, and the intellectual property market. Our customers are located throughout the world and include a wide range of medical device manufacturers and pharmaceutical companies, the U.S. government, numerous Patent Authorities, and IP-driven companies and law firms. The corporate mission is to advance humanity by delivering better outcomes to the innovation community. Reed Tech is a LexisNexis company.
For more information: Pharma@ReedTech.com, +1-215-557-3010
Would you like to learn more about how Reed Tech can streamline your medical device and pharma submissions? Speak to one of our experts!
Unique Device Identification (UDI)
Copyright © 2023 LexisNexis ReedTech. All Rights Reserved.